Home » Newsletters » BioWorld Science

BioWorld Science

May 24, 2016

View Archived Issues

Mutations in ZAS may be associated with congenital myopathy

Mersana's XMT-1536 targets tumors expressing sodium-dependent phosphate transport protein 2B

TRIP-13 identified as a therapeutic target in hepatocellular carcinoma

Vasohibin-1 shows promise as a therapeutic target for diabetic erectile dysfunction

Ionis and MD Anderson form strategic alliance to discover and develop novel cancer therapeutics

Darzalex receives European conditional marketing authorization for multiple myeloma

Positive topline results from a first-in-human trial of broad spectrum MVA-BN RSV vaccine

Catabasis' SREBP inhibitors show potential for NASH

Merck & Co. patent orexin receptor antagonists

ETHZ, Roche and Universität Zürich disclose CB2 receptor ligands

ECUST and SIMM report dipeptidyl peptidase IV inhibitors

Enanta Pharmaceuticals discloses farnesoid X receptor agonists

IOmet Pharma divulges indoleamine and tryptophan dioxygenase inhibitors

Bayer Schering Pharma announces t-PA inhibitors

New studies support utility of GastroPanel to predict stomach cancer risk

Advanced Accelerator Applications scales up Lutathera production

Survival benefit with Pentaglobin in severe infections caused by multidrug-resistant bacteria

Onoclys BioPharma announces licensing developments

FDA awards fast track designation for AEB-1102 in hyperargininemia

Boehringer Ingelheim and Biomed X establish a global research team

Avastin approved in Japan for cervical cancer

Phase III trial results presented for alirocumab in Japan

Alimera reports real world data on Iluvien in patients with DME

Exelixis reports phase II results for cabozantinib

Interim phase II data for bardoxolone methyl show improvement in renal function

Arbor Pharmaceuticals set to acquire XenoPort

ZVex/mIL12 shows promising antitumor effect in vivo

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...